Thus, the differences in the low expression of OCT 1 and 3 does not explain the increased dose needed to demonstrate an effect in vitro, and alternatively, this may be related to the hyperglycemic concentrations typically used to maintain and grow cancer cell lines in culture. This evidence concerns the gene POU2F1 and cancer.